Literature Archives

Whole-lung lavage remains a cornerstone IP procedure for PAP, but bronchoscopists must stay informed on competing medical therapies.

Liquid nitrogen cryospray represents a promising bronchoscopic intervention for targeted mucosal ablation and regeneration in severe chronic bronchitis.

Thoracentesis is the more cost-effective initial approach for cancers with pleural fluid cytology sensitivity greater than 27 percent, whereas medical thoracoscopy becomes more cost-effective for recurrent effusions following a negative thoracentesis.

For interventional pulmonologists, X-ray Velocimetry shows strong discriminative ability for pre-procedural collateral ventilation risk stratification with an AUC of 0.862 (P = 0.002), though it cannot yet replace intraoperative Chartis testing due to modest sensitivity.

Transbronchial cryobiopsy using a 1.1-mm probe through a therapeutic bronchoscope is safe and feasible, achieving an 87.5% overall diagnostic yield with significantly larger tissue samples than forceps biopsy and a 95.8% multiplex genetic testing success rate.

Clinicians can now use the newly derived RED score—incorporating baseline respiratory rate, ultrasound effusion depth, and dyspnoea—to predict time to the next procedure, yielding areas under the receiver operator curve of 0.73 and 0.75 in the derivation cohort.

Provides clinical insights regarding the management and recurrence timelines following pleural interventions.

Provides relevant prognostic context for patients undergoing medical thoracoscopy or pleural fluid management for malignant effusions.

Provides high-level evidence regarding optimal pleural intervention strategies for secondary spontaneous pneumothorax management.

Provides robust, multicenter prospective data supporting the clinical utility and safety of robotic bronchoscopy for peripheral pulmonary lesions.

Omitting patient rotation during doxycycline pleurodesis demonstrated identical 1-month success rates of 85% compared to the rotation group, supporting a simplified protocol to reduce patient burden.

Galaxy robotic bronchoscopy achieved a higher strict diagnostic yield than LungVision (87.6% versus 74.7%; OR 2.40, 95% CI 1.10-5.24; P = 0.03), though success was primarily driven by real-time imaging and tool-lesion alignment rather than platform type or breath-hold utilization.